ÀÖ²¥´«Ã½app×îа汾

Share of return on equity for Cipla Limited from financial year 2014 to 2026

© ÀÖ²¥´«Ã½app×îа汾 2026
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

June 2026

Region

India

Survey time period

FY 2014 to FY 2026

Supplementary notes

RoE is the product of Net Profit after tax attributable to shareholders divided by Average Shareholder’s Funds (excluding non-controlling Interest).

India's financial year begins in April and ends in March. For example, FY 2026 started in April 2025 and ended in March 2026. 

One Indian rupee is equal to 0.01 euros and 0.010 dollars as of August 2026. 

Values have been rounded for clarity.

Citation formats

Cipla's return on equity share FY 2014-2026

Published by A. Minhas, Aug 18, 2026

Cipla reported a **** percent return on its equity in fiscal year 2026.
Cipla is one of the leading biotechnology companies in India with a focus on respiratory, cardiovascular and diabetic diseases.

Log in or register to access precise data.
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

  • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 99 users
Talk to sales for pricing
Contact us
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Other statistics that may interest you

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Statistics on

About the industry

10

About the region

10

Selected statistics

10

Other regions

10

Related statistics

10

Further Content: You might find this interesting as well

Topics

Pharmaceutical industry in ChinaCoronavirus COVID-19 in ChinaPharmaceutical industry in JapanVaccine industry in ChinaPharmaceuticals in India
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

  • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 99 users
Talk to sales for pricing
Contact us
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how ÀÖ²¥´«Ã½app×îа汾 can support your business.